Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Thomas A. McGauley

Thomas A. McGauley is recorded as Chief Accounting Officer and CFO at Tenax Therapeutics, Inc. (TENX). Tenax Therapeutics, Inc. reported in an 8-K filed April 22, 2026 that Thomas A. McGauley resigned as Interim Chief Financial Officer, effective May 10, 2026. Tenax Therapeutics, Inc. reported in an 8-K filed December 4, 2024 that Thomas A. McGauley was appointed principal financial officer and principal accounting officer, effective December 2, 2024. Tenax Therapeutics, Inc. reported in an 8-K filed December 4, 2024 that Thomas A. McGauley was appointed Interim Chief Financial Officer, effective December 2, 2024.

“On April 21, 2026, in connection with the appointment of Mr. Staab as Chief Financial Officer of the Company, Mr. McGauley submitted his resignation as the Company’s Interim Chief Financial Officer, effective May 10, 2026.”
Tenax Therapeutics, Inc. Form 8-K, filed April 22, 2026 · Read the filing
“Mr. McGauley will be responsible for the Company's accounting and finance functions and will serve as the Company's principal financial officer and principal accounting officer beginning on the Start Date.”
Tenax Therapeutics, Inc. Form 8-K, filed December 4, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Tenax Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.